首页> 外国专利> Diagnosis and monitoring of colon cancer patients by measurement of NCA50 / 90 in the blood

Diagnosis and monitoring of colon cancer patients by measurement of NCA50 / 90 in the blood

机译:通过测量血液中NCA50 / 90对结肠癌患者的诊断和监测。

摘要

PURPOSE: To assist disgnosis of colon cancer of a patient by using an index for such cancer consisting of existence of a level at which the nonpeculiar crossing reaction antigen(NCA) 50/90 in his blood has increased significantly. ;CONSTITUTION: An antigen NCA 50/90 increases significantly in the blood of a patient suffering from colon cancer. The NCA 50/90 content of a blood specimen sampled from any person exhibiting an indication of colon cancer is measured and compared with the mean of NCA 50/90 in the normal population. Existence of the quantity level at which the NCA 50/90 content of the blood has increased significantly, is used as the index for colon cancer having propagated in the patient. This serves diagnosis of a patient exhibiting an indication of colon cancer, and a doctor uses it in diagnosis along with other information implying his suffering from colon cancer. An increment of blood NCA 50/90 level for a certain period shows usually a situation of worsening, while a sink shows situation that the decease situation has improved.;COPYRIGHT: (C)1994,JPO
机译:目的:通过使用这样的癌症指数来帮助诊断患者的结肠癌,该指数包括血液中非特殊交叉反应抗原(NCA)50/90显着增加的水平。组成:抗原NCA 50/90在患有结肠癌的患者的血液中显着增加。测量从显示结肠癌迹象的任何人采集的血液样本中NCA 50/90的含量,并将其与正常人群中NCA 50/90的平均值进行比较。血液中NCA 50/90含量显着增加的量水平的存在被用作已在患者中传播的结肠癌的指标。这有助于诊断出表现出结肠癌迹象的患者,医生将其与其他暗示他患有结肠癌的信息一起用于诊断。一段时间内血液中NCA 50/90水平的升高通常表明情况正在恶化,而下沉表明病情有所改善。;版权所有:(C)1994,JPO

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号